Form 4: Exagen CFO Jeffrey G. Black Reports Acquisition and Disposal of Common Stock

Chief Financial Officer of Exagen Inc., Jeffrey G. Black, reports acquiring 225,000 shares of common stock and disposing of 252,194 shares on September 1, 2024.

Summary

• On September 1, 2024, Jeffrey G. Black, the CFO of Exagen Inc., acquired 225,000 shares of common stock.
• These shares were acquired at a price of $0.
• On the same day, Mr. Black disposed of 252,194 shares of common stock.
• Following these transactions, Mr. Black beneficially owns 252,194 shares of Exagen Inc.
• The acquisition was in the form of restricted stock units under the company's 2019 Incentive Award Plan.
• Each restricted stock unit represents a contingent right to receive one share of Exagen's common stock.
• The restricted stock units vest in four equal installments on each anniversary of September 1, 2024, contingent upon continued service.
• The award may fully vest upon a qualifying termination of employment in connection with a change in control.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices. The acquisition of restricted stock units is a positive sign, aligning management's interests with shareholders. The disposal of shares is not explained, but the overall sentiment is neutral to slightly positive.

Positives

• The grant of restricted stock units aligns the CFO's interests with those of the shareholders, incentivizing long-term value creation.
• The vesting schedule encourages continued service and commitment from the CFO.

Future Outlook

The restricted stock units will vest over the next four years, subject to continued service, potentially impacting the CFO's holdings and incentives.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Similar grants of restricted stock units are common among publicly traded companies to incentivize and retain key executives.
• Vesting schedules typically range from three to five years, aligning with industry norms for long-term incentive plans.
• The specific terms of the vesting schedule and change-in-control provisions are comparable to those found in executive compensation packages at peer companies.

Stakeholder Impact

• Shareholders may view the grant of restricted stock units as a positive incentive for the CFO.
• Employees may see this as a standard part of executive compensation.

Key Dates